Demis Hassabis

Demis Hassabis is a British computer scientist, neuroscientist, and entrepreneur, born July 27, 1976 in London. He is the co-founder and chief executive officer of Google DeepMind, Alphabet's principal artificial intelligence research organization, and the founder and chief executive of Isomorphic Labs, the Alphabet drug-discovery subsidiary spun out of DeepMind in November 2021. As of May 2026, he runs both organizations in parallel, holds the 2024 Nobel Prize in Chemistry (shared with John Jumper and David Baker) for the AlphaFold protein-structure-prediction work, and was knighted in the 2024 King's Birthday Honours.

At a glance

• Education: Computer Science Tripos, Queens' College, Cambridge (1994 to 1997, double-first); PhD in cognitive neuroscience, University College London (2005 to 2009), supervised by Eleanor Maguire; postdoctoral fellow at the Gatsby Computational Neuroscience Unit, UCL (2009 to 2010).
• Current roles: Co-founder and Chief Executive Officer of Google DeepMind since 2010; Founder and Chief Executive of Isomorphic Labs since November 2021.
• Key contributions: co-founder of DeepMind (September 2010), AlphaGo (2015 to 2016), AlphaZero (December 2017), AlphaFold 2 (November 2020), AlphaFold 3 (May 2024), the Gemini family of models (2023 onwards).
• Awards: 2024 Nobel Prize in Chemistry; KBE 2024; CBE 2017; FRS (2018); FREng; Royal Society of Arts Fellow.
• X / Twitter: @demishassabis
• LinkedIn: Demis Hassabis
• Royal Society profile: royalsociety.org/people/demis-hassabis-13817
• Google DeepMind bio: deepmind.google/about/demis-hassabis

Origins

Hassabis grew up in north London, born to a Greek Cypriot father and a Chinese Singaporean mother. He learned chess at four and reached the master rating at thirteen with an Elo of 2300, the second-highest-rated under-fourteen player in the world at that time.

After Cambridge offered him a deferred place owing to his age, Hassabis spent his gap year in the British video-game industry. He joined Bullfrog Productions in 1991 through an Amiga Power "Win-a-job-at-Bullfrog" competition, and at seventeen co-designed and lead-programmed Theme Park (1994) under Peter Molyneux. He read Computer Science at Queens' College, Cambridge from 1994 to 1997, graduating with a double-first.

After Cambridge, Hassabis worked briefly at Lionhead Studios with Molyneux, then founded Elixir Studios in 1998 as a London-based independent developer. The studio shipped Republic: The Revolution (2003) and Evil Genius (2004), both simulation titles built around AI-driven systems, before closing in 2005. Hassabis returned to academia that year and completed a PhD in cognitive neuroscience at UCL Queen Square Institute of Neurology in 2009 under Eleanor Maguire, examining the role of the hippocampus in episodic memory and imagination. He spent 2009 to 2010 as a postdoctoral fellow at the Gatsby Computational Neuroscience Unit at UCL.

Career

Hassabis co-founded DeepMind Technologies in London in September 2010 with Shane Legg, a Gatsby Unit colleague, and Mustafa Suleyman, a school-era friend. The thesis was that progress toward artificial general intelligence would come from combining deep learning with reinforcement learning and ideas drawn from neuroscience. Early work focused on Atari 2600 video games and the publication of "Human-level control through deep reinforcement learning" in Nature in February 2015.

Google acquired DeepMind in January 2014. Per industry coverage at the time, the deal was reported at approximately 400 million pounds ($650 million in then-current terms). Hassabis remained chief executive through and after the acquisition, with the lab operating as a semi-autonomous London-based subsidiary inside Google and, from 2015, the broader Alphabet holding company.

The AlphaGo Lee Sedol match in March 2016 in Seoul was the public inflection point. AlphaGo defeated the 9-dan Go professional Lee Sedol 4 to 1 in a five-game series watched by an estimated 200 million people online; it was the first program to beat a top professional Go player without handicap. AlphaZero followed in December 2017, generalizing the approach to chess, shogi, and Go from self-play with no human game data.

AlphaFold 2, released in November 2020, produced near-experimental accuracy at the CASP14 community benchmark, treated by the structural-biology field as a solved problem for single-chain structures. In November 2021 Hassabis founded Isomorphic Labs as an Alphabet subsidiary spun out of DeepMind, with a remit to apply DeepMind's modeling work to drug discovery; he holds the chief-executive role at Isomorphic in parallel with the DeepMind role.

In April 2023 Alphabet merged DeepMind with the Google Brain research organization to form Google DeepMind, in response to OpenAI's commercial traction following the November 2022 launch of ChatGPT. Hassabis was named chief executive of the consolidated organization; Jeff Dean was named chief scientist of Google, reporting to Sundar Pichai.

The Nobel Prize in Chemistry was announced on October 9, 2024, divided one half to David Baker for computational protein design and the other half jointly to Hassabis and John Jumper for protein structure prediction. AlphaFold 3, co-developed by Google DeepMind and Isomorphic Labs, was published in Nature on May 8, 2024, extending the system to protein-ligand, protein-DNA, and protein-RNA interactions on a single diffusion-based architecture. Hassabis was knighted in the 2024 King's Birthday Honours, announced in late March 2024, for services to artificial intelligence. As of May 2026, he continues as chief executive of both Google DeepMind and Isomorphic Labs.

Affiliations

• Google DeepMind: Co-founder and CEO, 2010 to present
• Isomorphic Labs: Founder and CEO, 2021-11 to present

Notable contributions

Hassabis's contributions span research direction, applied systems, and organization-building.

• AlphaGo (2015 to 2016). The first program to defeat a 9-dan professional Go player without handicap. The Lee Sedol match in Seoul in March 2016 ended 4 to 1 in AlphaGo's favor and is widely treated as the public moment at which deep reinforcement learning crossed into mainstream awareness.
• AlphaZero (December 2017). Generalized the AlphaGo approach to chess, shogi, and Go from self-play alone, with no human game data, opening books, or endgame tables.
• AlphaFold 2 (November 2020). Won the CASP14 protein-structure-prediction benchmark at near-experimental accuracy. The 2021 release of structures for nearly all 200 million proteins in the UniProt database, jointly with the European Bioinformatics Institute, made the model the central reference for structural biology.
• AlphaFold 3 (May 2024). Published in Nature on May 8, 2024, jointly by Google DeepMind and Isomorphic Labs. The diffusion-based architecture extends AlphaFold to protein-ligand, protein-DNA, protein-RNA, and modified-residue interactions on a single model.
• AlphaProteo (2024). De-novo protein-binder design from DeepMind, generating novel proteins that bind to specified targets at higher affinity than known designs.
• Genie / Genie 2 (2024 onwards). DeepMind's world-model line, generating interactive 2D and 3D environments from a single image input.
• Gemini family (December 2023 onwards). DeepMind's flagship multimodal foundation-model line, shipped through Gemini 1, 1.5, 2, and 2.5 generations across 2024 and 2025 and into the Gemini 3 series in 2026, distributed through Google Search, Workspace, Android, and the Gemini app.
• Game-industry artifacts (1991 to 2005). Theme Park at seventeen, then Republic: The Revolution and Evil Genius at Elixir Studios.
• 2024 Nobel Prize in Chemistry, shared with John Jumper and David Baker, for protein structure prediction. Hassabis's Nobel Lecture, "Accelerating scientific discovery with AI," was delivered at Stockholm University on December 8, 2024.
• KBE 2024 for services to artificial intelligence; CBE 2017; FRS 2018; FREng.

Investments and boards

Hassabis's footprint in this section is concentrated in his two operating roles at Alphabet subsidiaries rather than personal angel investing. No public personal angel-investment activity in AI, semiconductors, datacenters, software, or energy is on record as of May 2026.

• Google DeepMind (AI): Co-founder and CEO, 2010 onwards. Subsidiary of Google from January 2014; merged with Google Brain in April 2023 to form Google DeepMind, with Hassabis as chief executive of the consolidated organization.
• Isomorphic Labs (AI): Founder and CEO, 2021 onwards. Alphabet drug-discovery subsidiary spun out of DeepMind in November 2021. Raised a $600 million external round led by Thrive Capital with GV and Alphabet participation in March 2025.

Academic and learned-society posts (Royal Society Fellowship 2018, Royal Academy of Engineering Fellowship, Pontifical Academy of Sciences) are honors rather than corporate-board roles and sit outside the Investments-and-boards filter.

Network

Hassabis's longest-running professional relationships sit inside DeepMind. Shane Legg, the co-founder he met at the Gatsby Computational Neuroscience Unit in 2009, has remained at DeepMind throughout and serves as Chief AGI Scientist. Mustafa Suleyman, the third co-founder, departed DeepMind in 2019 to found Inflection AI and now leads Microsoft AI. John Jumper, Hassabis's co-Nobel laureate and the technical lead on AlphaFold, runs DeepMind's protein-modeling work. David Baker at the University of Washington is the third laureate of the 2024 prize and a longstanding counterpart in the protein-design community. Eleanor Maguire was Hassabis's PhD advisor at UCL. The principal corporate-parent counterparties at Alphabet are Sundar Pichai, Jeff Dean, and historically Larry Page at the time of the 2014 acquisition.

Position in the field

Hassabis is the longest-tenured chief executive among frontier-lab leaders. DeepMind has operated continuously under his leadership for sixteen years as of May 2026, spanning the 2014 Google acquisition and the 2023 Brain merger. The 2024 Nobel Prize in Chemistry is the first awarded for work performed inside an industrial AI laboratory; combined with the FRS, KBE, and Royal Academy of Engineering memberships, the credential stack is structurally distinct from operator-investor profiles like Sam Altman at OpenAI. The closest comparator on the academic-credential axis is Yann LeCun, the 2018 Turing laureate.

The Google DeepMind organization ships the Gemini model family into Google Search, Workspace, Android, and the Gemini app, giving Hassabis distribution to several billion users through Alphabet's existing surfaces. The dual-organization structure (DeepMind plus Isomorphic Labs as an Alphabet drug-discovery vehicle) makes him the archetype of the corporate-research-org leader covered on Nextomoro.

Outlook

Open questions over the next 6 to 18 months:

• Isomorphic Labs first-in-human trials. ISM8969 received FDA clearance for human clinical trials in late January 2026 per industry coverage. The first dosing milestone is the watchable signal, alongside any further pharma partnerships beyond Eli Lilly and Novartis.
• Gemini 3 successor releases. Competitive position of the Gemini line versus the GPT-5 family from OpenAI, the Claude line from Anthropic, and the Grok line from xAI at the next benchmark and product cycles.
• AlphaFold lineage. Successor work after AlphaFold 3 and integration of the Isomorphic Labs drug-design engine.
• Dual-CEO sustainability. Whether Hassabis continues to run both organizations in parallel as both grow, or whether Isomorphic transitions to a separate operating chief executive.
• Alphabet AI strategy. The role Google DeepMind plays inside Alphabet's broader product strategy under Sundar Pichai.
• Public commentary. Positioning on AGI timelines, AI safety, and policy compared to Altman, Amodei, and LeCun.

Sources

• Demis Hassabis. Wikipedia biographical entry; covers career, awards, publications, and the games-industry period.
• Sir Demis Hassabis CBE FREng FRS. Royal Society Fellow profile with election year and citation.
• Demis Hassabis & John Jumper awarded Nobel Prize in Chemistry. Google DeepMind statement on the October 2024 Nobel announcement.
• Press release: The Nobel Prize in Chemistry 2024. NobelPrize.org official citation, joint to Hassabis, Jumper, and Baker.
• Announcing Google DeepMind. The April 2023 announcement of the DeepMind / Brain merger and Hassabis's elevation to chief executive of the consolidated organization.
• Google DeepMind CEO Demis Hassabis gets UK knighthood for 'services to artificial intelligence'. TechCrunch on the March 2024 KBE announcement.
• Accurate structure prediction of biomolecular interactions with AlphaFold 3. The May 8, 2024 Nature publication, jointly authored by Google DeepMind and Isomorphic Labs.
• Isomorphic Labs. Wikipedia entry; covers the November 2021 founding, Eli Lilly and Novartis partnerships, and the March 2025 funding round.
• Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind. CNBC profile of Isomorphic ahead of clinical trials.
• AlphaGo versus Lee Sedol. Wikipedia entry on the March 2016 Seoul match.
• Demis Hassabis. Encyclopaedia Britannica biographical entry; concise reference for the games-industry, neuroscience, and DeepMind periods.
• Photo: Wikipedia entry on Demis Hassabis, CC-BY-SA 4.0 Johnsearsmedia (2024 Nobel Prize ceremony, Stockholm, December 2024).